| Exposure to anti-malarial(s) during first trimester | ||||
---|---|---|---|---|---|
 | AL only (N = 133) | AL plus SP (N = 7) | SP or/and quinine (N = 126) | None (N = 627) | Unknown (N = 40) |
Total number of infants with malformations (%) | 9/130 (6.9) | 0/7 (-) | 8/121 (6.6) | 27/596 (4.5) | 3/39 (7.7) |
Umbilical hernia4 | 8 (6.2) | 0 (-) | 5 (4.1) | 20 (3.4) | 0 (-) |
Polydactyly | 0 (-) | 0 (-) | 1 (0.8) | 4 (0.7) | 2 (5.1) |
Dermal cyst | 0(-) | 0 (-) | 1 (0.8) | 0 (-) | 0 (-) |
Ear malformation | 0 (-) | 0 (-) | 1 (0.8) | 0 (-) | 0 (-) |
Genitourinary system: small labia1 | 1 (0.8) | 0 (-) | 0 (-) | 0 (-) | 0 (-) |
Hair: lanugo1 | 1 (0.8) | 0 (-) | 0 (-) | 0 (-) | 0 (-) |
Inguinal hernia | 0 (-) | 0 (-) | 0 (-) | 1 (0.2) | 0 (-) |
Limbs: hyperextensibility of joint | 0 (-) | 0 (-) | 0 (-) | 0 (-) | 1 (2.6) |
Nose: small1 | 1 (0.8) | 0 (-) | 0 (-) | 0 (-) | 0 (-) |
Skin hyperpigmentation | 0 (-) | 0 (-) | 0 (-) | 1 (0.2) | 0 (-) |
Trisomy 182 | 0 (-) | 0 (-) | 0 (-) | 1 (0.2) | 0 (-) |
Trisomy 213 | 0 (-) | 0 (-) | 0 (-) | 1 (0.2) | 0 (-) |